British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
- PMID: 35355064
- PMCID: PMC9398208
- DOI: 10.1093/rheumatology/keac115
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
Keywords: DMARDs; adolescent rheumatology; immunosuppressants; muscle; myositis; paediatric/juvenile rheumatology.
References
-
- Meyer A, Meyer N, Schaeffer M. et al. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 2021;54:50–63. - PubMed
-
- Scottish Intercollegiate Guidelines Network. SIGN 50 – A Guideline Developer’s Handbook. 2011. https://www.sign.ac.uk/assets/sign50_2011.pdf (10 February 2022, date last accessed).
-
- Tomasova Studynkova J, Mann H, Jarosova K. et al. OP0289 a prospective, randomized, open-label, assessor-blind, multicenter study of efficacy and safety of combined treatment of methotrexate + glucocorticoids versus glucocorticoids alone in patients with polymyositis and dermatomyositis (prometheus trial). Ann Rheum Dis 2014;73:171.
-
- Ueno KI, Shimojima Y, Kishida D, Sekijima Y, Ikeda SI.. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis. Int J Rheum Dis 2016;19:1322–30. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical